Explore

Trendline Trendline
AN2 Therapeutics Reports Q1 2026 Financial Results and Advances Clinical Programs

AN2 Therapeutics Reports Q1 2026 Financial Results and Advances Clinical Programs

AN2 Therapeutics Reports Q1 2026 Financial Results and Advances Clinical Programs
Trendline Trendline
AN2 Therapeutics Advances Multiple Clinical Programs with Boron Chemistry Platform

AN2 Therapeutics Advances Multiple Clinical Programs with Boron Chemistry Platform

AN2 Therapeutics Advances Multiple Clinical Programs with Boron Chemistry Platform
Trendline Trendline
AN2 Therapeutics Advances Multiple Drug Programs with New Phase 2 Trials

AN2 Therapeutics Advances Multiple Drug Programs with New Phase 2 Trials

AN2 Therapeutics Advances Multiple Drug Programs with New Phase 2 Trials
Trendline Trendline
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments
Trendline Trendline
Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments
Trendline Trendline
Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates

Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates

Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates
Trendline Trendline
Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026

Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026

Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026
Trendline Trendline
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Trendline Trendline
Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call

Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call

Omeros Corporation to Release First Quarter 2026 Financial Results and Host Conference Call
Trendline Trendline
Crescita Reports Increased Revenue and Gross Profit in Q1 2026

Crescita Reports Increased Revenue and Gross Profit in Q1 2026

Crescita Reports Increased Revenue and Gross Profit in Q1 2026
Trendline Trendline
Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results with Net Loss

Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results with Net Loss

Nika Pharmaceuticals Reports First-Quarter 2026 Financial Results with Net Loss
Trendline Trendline
FORE Biotherapeutics to Engage in Key Investor Conferences, Highlighting Oncology Innovations

FORE Biotherapeutics to Engage in Key Investor Conferences, Highlighting Oncology Innovations

FORE Biotherapeutics to Engage in Key Investor Conferences, Highlighting Oncology Innovations